These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37558414)

  • 1. [Rectal cancer with multiple metastases complicated by Crohn's disease 5 years after surgery:a case report].
    Higashiura R; Sakakibara Y; Ishida H; Hasegawa H; Tanaka S; Fukutake N; Yamamoto S; Sakamori R; Mori K; Mita E
    Nihon Shokakibyo Gakkai Zasshi; 2023; 120(8):671-679. PubMed ID: 37558414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab.
    Medvecz M; Kiss N; Hársing J; Kuroli E; Hegede G; Csomor J; Kárpáti S; Marschalkó M
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):202-204. PubMed ID: 31542070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colorectal Cancer Associated with Crohn's Disease-A Case Report].
    Fukushima G; Ishizaki T; Wada A; Mazaki J; Enomoto M; Nagakawa Y; Katsumata K; Tsuchida A
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2515-2517. PubMed ID: 32156983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anorectal carcinoma after infliximab therapy in Crohn's disease: report of a case.
    Melichar B; Bures J; Dedic K
    Dis Colon Rectum; 2006 Aug; 49(8):1228-33. PubMed ID: 16845561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
    Rodríguez-Lago I; Hoyo JD; Pérez-Girbés A; Garrido-Marín A; Casanova MJ; Chaparro M; Fernández-Clotet A; Castro-Poceiro J; García MJ; Sánchez S; Ferreiro-Iglesias R; Bastón I; Piqueras M; Careda LEIB; Mena R; Suárez C; Cordón JP; López-García A; Márquez L; Arroyo M; Alfambra E; Sierra M; Cano N; Delgado-Guillena P; Morales-Alvarado V; Aparicio JC; Guerra I; Aulló C; Merino O; Arranz L; Hidalgo MA; Llaó J; Plaza R; Molina G; Torres P; Pérez-Galindo P; Romero MG; Herrera-deGuise C; Armesto E; Mesonero F; Frago-Larramona S; Benítez JM; Calvo M; Martín MDCL; Elorza A; Larena A; Peña E; Rodríguez-Grau MDC; Miguel-Criado J; Botella B; Olmos JA; López L; Aguirre U; Gisbert JP;
    United European Gastroenterol J; 2020 Nov; 8(9):1056-1066. PubMed ID: 32723069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transperineal total mesorectal excision for rectal cancer on the residual rectum after multiple abdominal surgeries in a patient with Crohn's disease: a case report.
    Emoto S; Homma S; Yoshida T; Ichikawa N; Miyaoka Y; Matsui H; Takahashi R; Ishido K; Otsuka T; Mitsuhashi T; Katsurada T; Taketomi A
    Surg Case Rep; 2021 May; 7(1):122. PubMed ID: 33983535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Case of Synchronous Double Colitic Cancer in Crohn's Disease].
    Urakawa N; Yamashita K; Kanemitsu K; Sumi Y; Suzuki S; Kakeji Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2202-4. PubMed ID: 26805311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
    Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis.
    Singh S; Murad MH; Fumery M; Sedano R; Jairath V; Panaccione R; Sandborn WJ; Ma C
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1002-1014. PubMed ID: 34688373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenocarcinoma associated with perianal fistulas in Crohn's disease.
    Ogawa H; Haneda S; Shibata C; Miura K; Nagao M; Ohnuma S; Kohyama A; Unno M
    Anticancer Res; 2013 Feb; 33(2):685-9. PubMed ID: 23393368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative infliximab is not associated with an increase in adverse events in Crohn's disease.
    Regueiro M; El-Hachem S; Kip KE; Schraut W; Baidoo L; Watson A; Swoger J; Schwartz M; Barrie A; Pesci M; Binion D
    Dig Dis Sci; 2011 Dec; 56(12):3610-5. PubMed ID: 21681507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
    Kennedy NA; Heap GA; Green HD; Hamilton B; Bewshea C; Walker GJ; Thomas A; Nice R; Perry MH; Bouri S; Chanchlani N; Heerasing NM; Hendy P; Lin S; Gaya DR; Cummings JRF; Selinger CP; Lees CW; Hart AL; Parkes M; Sebastian S; Mansfield JC; Irving PM; Lindsay J; Russell RK; McDonald TJ; McGovern D; Goodhand JR; Ahmad T;
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):341-353. PubMed ID: 30824404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and Maintenance Infliximab Therapy for the Treatment of Crohn's Disease with Perianal Fistulas in Children: Retrospective, Multicenter Study.
    Iwańczak BM; Ryżko J; Jankowski P; Sładek M; Wasilewska A; Szczepanik M; Sienkiewicz E; Szaflarska-Popławska A; Więcek S; Kwiecień J; Korczowski B; Maślana J
    Adv Clin Exp Med; 2016; 25(3):523-30. PubMed ID: 27629741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perianal Crohn's Disease and the Development of Colorectal and Anal Cancer: A Systematic Review and Meta-analysis.
    Johansen MP; Wewer MD; Nordholm-Carstensen A; Burisch J
    J Crohns Colitis; 2023 Apr; 17(3):361-368. PubMed ID: 36130090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer complicating Crohn's disease.
    Freeman HJ
    Can J Gastroenterol; 2001 Apr; 15(4):231-6. PubMed ID: 11331924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal cancer and inflammatory bowel disease: natural history and implications for radiation therapy.
    Green S; Stock RG; Greenstein AJ
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):835-40. PubMed ID: 10386640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial.
    Stevens TW; Haasnoot ML; D'Haens GR; Buskens CJ; de Groof EJ; Eshuis EJ; Gardenbroek TJ; Mol B; Stokkers PCF; Bemelman WA; Ponsioen CY;
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):900-907. PubMed ID: 32619413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.